Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 761 across all filing types
Latest filing 2025-09-29 Management Reports
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
Sprawozdanie Zarządu z działalności
Management Reports Classification · 95% confidence The document is a 'Sprawozdanie zarządu na temat działalności' (Management Report on Operations) for Medinice S.A. covering the period from 01.01.2025 to 30.06.2025. It contains detailed management commentary, business trends, risk factors, and corporate governance information. While it is part of the interim reporting package, it specifically functions as the Management Discussion and Analysis (MDA) component of the interim report, providing the narrative and operational context for the financial results. H1 2025
2025-09-29 Polish
Raport śródroczny GK Medinice za pierwsze półrocze 2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Raport śródroczny' (Interim Report) for the period 01.01.2025 to 30.06.2025 for Grupa Kapitałowa Medinice S.A. It contains detailed consolidated financial statements, including the statement of financial position and statement of comprehensive income, which confirms it is a substantive financial report rather than an announcement or a summary. Therefore, it is classified as an Interim/Quarterly Report. H1 2025
2025-09-29 Polish
Korekta raportu półrocznego za okres 01.01.2025 do 30.06.2025
Regulatory Filings Classification · 95% confidence The document is a 'Raport Bieżący' (Current Report) issued by Medinice S.A. regarding a correction to a previously published semi-annual report. It serves as a formal regulatory notification explaining an administrative error (the omission of a management statement) and does not contain the actual financial statements or substantive financial data itself. According to the 'Regulatory Filings' fallback rule and the nature of the document as a formal announcement of a correction, it is classified as RNS. H1 2025
2025-09-29 Polish
Oświadczenie Zarządu
Regulatory Filings Classification · 100% confidence The document is a formal 'Oświadczenie Zarządu' (Management Statement) certifying the accuracy of financial reports. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report (in this case, an interim report), should be classified as Regulatory Filings (RNS) rather than the report itself. The document does not contain the actual financial statements, only a statement confirming their validity. H1 2025
2025-09-29 Polish
Korekta raportu półrocznego za okres 01.01.2025 do 30.06.2025 - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a short announcement (1551 characters) from Medinice S.A. regarding a correction to a previously published semi-annual report. It explains that a required management statement was omitted due to an error and that the company is now providing that statement. Since this is a short notification about a filing correction rather than the financial report itself, it falls under the category of a regulatory announcement or filing.
2025-09-29 Polish
Podpisanie listu intencyjnego - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement regarding a signed letter of intent (LOI) between Medinice S.A. and Qingdao NovelBeam Technology Co., Ltd. to collaborate on R&D projects in cardiology and medical robotics. It details the nature of the partnership, potential synergies, and a proposed funding amount. Since this is a corporate announcement regarding a strategic business development/partnership and does not fit into specific categories like M&A (which usually implies a takeover or merger) or financial reporting, it falls under the general regulatory announcement category.
2025-09-26 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.